Pentraxin-3 in coronary artery disease: A meta-analysis.

Chu, Yi; Teng, Jiwei; Feng, Pin; Liu, Hui; Wang, Fangfang; Li, Xue

Chu, Yi; Teng, Jiwei; Feng, Pin; Liu, Hui; Wang, Fangfang; Li, Xue.

Afiliação

Chu Y; Department of Cardiology, The Second Affiliated Hospital of Air Force Medical University, Xi'an 710038, PR China.
Teng J; Department of Cardiology, The Second Affiliated Hospital of Air Force Medical University, Xi'an 710038, PR China.
Feng P; Department of Cardiology, The Second Affiliated Hospital of Air Force Medical University, Xi'an 710038, PR China.
Liu H; Department of Cardiology, The Second Affiliated Hospital of Air Force Medical University, Xi'an 710038, PR China.
Wang F; Department of Cardiology, The Second Affiliated Hospital of Air Force Medical University, Xi'an 710038, PR China.
Li X; Department of Cardiology, The Second Affiliated Hospital of Air Force Medical University, Xi'an 710038, PR China. Electronic address: lixuexian01@yeah.net.

Cytokine ; 119: 197-201, 2019 07.

Article em En | MEDLINE | ID: mdl-30954865

Assuntos

Proteína C-Reativa/metabolismo; Doença da Artéria Coronariana/metabolismo; Componente Amiloide P Sérico/metabolismo; Estudos de Casos e Controles; Doença da Artéria Coronariana/patologia; Humanos; Prognóstico; Estudos Prospectivos; Estudos Retrospectivos; Risco; Fatores de Risco

Palavras-chave

All-cause mortality; Cardiac events; Coronary artery disease; Meta-analysis; Pentraxin-3

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença da Artéria Coronariana / Proteína C-Reativa / Componente Amiloide P Sérico Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google